The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China
Clinical trial NCT04228393 · UNKNOWN
Trial details
- NCT number
- NCT04228393
- Sponsor
- Wei Zhao
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2022-12-31
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.